The global transgenic animal model market is projected to grow to $6.79 billion by 2035, fueled by advances in CRISPR-Cas9 technology and rising demand for precise preclinical testing in drug development. Rodents dominate the market, with pharmaceutical and biotech companies as the main users, especially in oncology and personalized medicine. North America leads due to strong biopharma R&D and infrastructure. Despite challenges like high costs and ethical concerns, innovations in gene editing and AI integration promise continued market expansion and improved drug discovery outcomes.
XRP's market capitalization has surged past $94 billion, exceeding Belarus' estimated 2025 GDP of $93.4 billion. This milestone highlights XRP's rapid growth, also surpassing the market cap of major financial firm Intercontinental Exchange. Meanwhile...
Bitcoin surged past $79,000 after breaking a six-week range, driven by strong spot demand and $1.92 billion inflows into U.S. spot Bitcoin ETFs over five days. This rally, supported by short-term holders reclaiming cost bases near $68,500 and a $3 bi...
Micron Technology is expected to see a modest stock price increase of about 1.4% by September 1, 2026, reaching an average price of $980. This forecast is based on a machine learning model combining multiple AI tools and technical indicators. The com...
Michael Saylor reaffirmed his view of Bitcoin as digital economic energy that can be securely controlled by individuals, companies, or governments. Strategy, the company he leads, holds 840,447 Bitcoin, about 4% of the total supply, valued at $64.86 ...
Solana's real-world asset (RWA) ecosystem surpassed $4 billion in total value for the first time in August 2026, nearly tripling from $1.4 billion in January. This growth was steady, with $263 million in net inflows over 30 days, contrasting Ethereum...
